Bafna Pharma Live Share Price Today, Share Analysis and Chart

Name: Bafna Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Bafna Pharmaceuticals Ltd.
Rating: 2.982583375
Author: Trendlyne DVM scores

Mid-range Performer

Iran war impact

The impact of the Iran-Israel war on Bafna Pharmaceuticals Ltd. (BAFNAPH) is primarily negative due to supply chain disruptions and escalating operational costs, although its direct revenue exposure to the Middle East is relatively limite...

123.76 9.56 (8.37%)

38.75% Fall from 52W High

1,416

NSE+BSE Volume

NSE 08 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

48.9 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

No estimates available

Bafna Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Bafna Pharmaceuticals Ltd. worth buying?

25 Votes:

Buy 68.0%

Sell 24.0%

Hold 8.0%

Bafna Pharma Live Share Price Today, Share Analysis and Chart

The impact of the Iran-Israel war on Bafna Pharmaceuticals Ltd. (BAFNAPH) is primarily negative due to supply chain disruptions and escalating operational costs, although its direct revenue exposure to the Middle East is relatively limite...

38.75% Fall from 52W High

SWOT Analysis

Bafna Pharma Live Price Chart